PharmaCyte Biotech Inc (PMCB)

[rudygerner]

If the JDRF and the FDA like artificial pancreas systems utilizing insulin pumps, continuous glucose monitors and smart software then their going to love what we have. http://www.jdrf.org/press-releases/jdrf-celebrates-fda-approval-of-artificial-pancreas-system/

The Cell-in-a-Box®/Melligen cell combo to treat diabetes requires no daily injections of insulin, no more pricking fingers multiple times daily to check blood sugar and no insulin pumps or plastic devices to be inserted beneath the skin - just one simple injection of Cell-in-a-Box® capsules is all that's required and the capsules can stay in the body up to two years. No fuss, no muss. Doesn't get any easier than that.

The future of diabetes treatment is encapsulation and we own the best encapsulation technology on the planet. http://www.jdrf.org/wp-content/uploads/2013/07/Encapsulation-White-Paper-Final-.pdf

Chicago Diabetes Project (http://www.chicagodiabetesproject.org/), Harvard Stem Cell Institute (http://hsci.harvard.edu/diabetes-0) and even the JDRF Consortium (http://www.jdrf.org/wp-content/uploads/2013/07/Encapsulation-White-Paper-Final-.pdf) all share a major problem: they all need a bioinert material to protect their insulin producing beta cells from immune attack. Cell-in-a-Box® is the answer.